In Consulting Services

PharmaNet offers a comprehensive range of early- and late-phase consulting services on topics including: international regulatory affairs; scientific and medical affairs; quality; risk management; chemistry, manufacturing and controls; as well as biopharmaceutical investor issues.

Submission Strategy

A well-designed regulatory submission meets the information needs of all relevant stakeholders, without supplying extraneous data. PharmaNet Consulting professionals can assist you in devising a strategy to collect only the data that support your endpoints, while enabling you to meet both your business objectives and your obligation to the safety of study participants.

 

PharmaNet professionals available for consultation on this topic include:

 

Andrew Chang, PhD

Executive Director, PharmaNet Consulting

 

Bengt Danielsson, MD, PhD

Vice President, PharmaNet Consulting

 

William M. Egan, PhD

Vice President, PharmaNet Consulting

 

Joyce Lea Frey-Vasconcells, PhD

Executive Director, PharmaNet Consulting

 

Gregory M. Hockel, MBA, PhD

Senior Vice President, Regulatory Affairs Worldwide

 

Mary F. Johnson, PhD

Executive Vice President, Biostatistics

 

Mario Tanguay, BPharm, PhD

Vice President, Scientific and Regulatory Affairs, Anapharm

 

Duu-Gong Wu, PhD

Executive Director, PharmaNet Consulting

 

PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390